Clinical and pathologic predictors of complete pathologic response to neoadjuvant docetaxel/anthracycline chemotherapy in breast cancer patients.

被引:0
|
作者
Coplin, M [1 ]
Naughton, M [1 ]
机构
[1] Washington Univ, St Louis, MO USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
836
引用
收藏
页码:85S / 85S
页数:1
相关论文
共 50 条
  • [31] Association of higher axillary pathologic complete response rate with breast pathologic complete response after neoadjuvant chemotherapy
    Zhu, Jiujun
    Li, Jianbin
    Fan, Zhimin
    Wang, Haibo
    Zhang, Jianguo
    Yin, Yongmei
    Fu, Peifen
    Geng, Cuizhi
    Jin, Feng
    Jiang, Zefei
    Liu, Zhenzhen
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (16)
  • [32] Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
    Jiralerspong, Sao
    Palla, Shana L.
    Giordano, Sharon H.
    Meric-Bernstam, Funda
    Liedtke, Cornelia
    Barnett, Chad M.
    Hsu, Limin
    Hung, Mien-Chie
    Hortobagyi, Gabriel N.
    Gonzalez-Angulo, Ana M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (20) : 3297 - 3302
  • [33] Predictors of Pathologic Complete Response to Neoadjuvant Chemotherapy in Stage II and III Breast Cancer: the Impact of Chemotherapeutic Regimen
    Nwaogu, Iheoma
    Fayanju, Oluwadamilola M.
    Yan, Yan
    Jeffe, Donna B.
    Margenthaler, Julie A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : 86 - 87
  • [34] Predictors and long-term outcome of pathologic complete response in patients receiving neoadjuvant chemotherapy for breast cancer - an NCDB analysis
    Panebianco, Lauren Mikesell
    Kumar, Prashanth Ashok
    Sinha, Shreya
    Wang, Dongliang
    Huang, Danning
    Sivapiragasam, Abirami
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [35] Predictors of recurrence among patients with breast cancer who achieved a pathologic complete response (pCR) after neoadjuvant systemic chemotherapy
    Chavez-MacGregor, M.
    Lei, X.
    Litton, J. K.
    Melhem, A.
    Mittendorf, E. A.
    Meric-Bernstam, F.
    Sahin, A. A.
    Valero, V.
    Hortobagyi, G. N.
    Gonzalez-Angulo, A. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [36] Correlation between breast and axillary pathologic complete response after neoadjuvant chemotherapy in breast cancer
    Yildirim, Emine
    Bektas, Sibel
    Yetis, Firat
    Yildiz, Eren Ozan
    Ozdemir, Muhammed
    Komut, Neslihan
    Calik, Mustafa
    Er, Ahmet Muzaffer
    [J]. ANNALI ITALIANI DI CHIRURGIA, 2023, 94 (04) : 336 - 345
  • [37] MRI and Prediction of Pathologic Complete Response in the Breast and Axilla after Neoadjuvant Chemotherapy for Breast Cancer
    Weber, Joseph J.
    Jochelson, Maxine S.
    Eaton, Anne
    Zabor, Emily C.
    Barrio, Andrea V.
    Gemignani, Mary L.
    Pilewskie, Melissa
    Van Zee, Kimberly J.
    Morrow, Monica
    El-Tamer, Mahmoud
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 225 (06) : 740 - 746
  • [38] Neoadjuvant Chemotherapy of Breast Cancer: Tumor Markers as Predictors of Pathologic Response, Recurrence, and Survival
    Precht, Lisa M.
    Lowe, Kimberly A.
    Atwood, Mary
    Beatty, J. David
    [J]. BREAST JOURNAL, 2010, 16 (04): : 362 - 368
  • [39] Quantitative MR Imaging Features Associated with Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
    Jimenez, J.
    Abeer, A.
    Elshafeey, N.
    Yung, J.
    Hazle, J.
    Rauch, G.
    [J]. MEDICAL PHYSICS, 2020, 47 (06) : E550 - E551
  • [40] Risk factors of breast cancer recurrence in pathologic complete response achieved patients following neoadjuvant chemotherapy
    Choi, J. Y.
    Woen, D.
    Jang, S. Y.
    Lee, H.
    Shin, D. S.
    Kwak, Y.
    Chae, B. -J.
    Yu, J.
    Kim, S. W.
    Lee, J. E.
    Nam, S. J.
    Ryu, J. M.
    [J]. BREAST, 2023, 68 : S72 - S72